Henrik Børsting Jacobsen

Henrik Børsting Jacobsen

Auto-generated profile, based on publicly available information

Henrik Børsting Jacobsen

Department of Psychology, University of Oslo, Forskningsveien 3A, 0373, Oslo, Norway

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in Journal of Occupational and Environmental Medicine
Verified
Journal Article
Closed access
HJHenrik Borsting PsyD Jacobsen
Henrik Borsting PsyD Jacobsen
Alberto J. Caban-MartinezAlberto J. Caban-Martinez
Alberto J. Caban-Martinez
LOLynn C. Msc Onyebeke
Lynn C. Msc Onyebeke
GSGlorian Sorensen
Glorian Sorensen
JDJack Dennerlein
Jack Dennerlein
SRSilje Endresen PsyD Reme
Silje Endresen PsyD Reme
Objectives: We aimed to investigate how mental distress was associated with pain and injuries in a convenience sample of construction workers. Methods: A cross-sectional, mental health assessment was conducted in a convenience sample of construction workers (N = 172). A subsample participated in a clinical interview (n = 10). We used a cutoff (1.50 or greater) on Hopkins Symptom Checklist–25 to determine substantial mental distress and determined associations with pain and injury outcomes. Results: The prevalence of substantial mental distress was 16% in the workers. This was supported by follow-up clinical interviews where 9 of 10 workers fulfilled the criteria for a mental disorder. Substantial mental distress was associated with both injury rate and self-reported pain. Conclusion: This pilot study strongly suggests the need for rigorous studies on construction worker mental health and how it affects their work and well-being.

1 January 2021 in Pain Reports
Verified
Journal Article
Open access
SRStefanie Rehm
Stefanie Rehm
JSJuliane Sachau
Juliane Sachau
JHJana Hellriegel
Jana Hellriegel
JFJulia Forstenpointner
Julia Forstenpointner
HJHenrik Børsting Jacobsen
Henrik Børsting Jacobsen
RBRalf Baron
Ralf Baron
Introduction: Patients suffering from fibromyalgia syndrome (FMS) are heterogenous. They often present with sensory abnormalities and comorbidities. Objectives: We aimed to answer the following questions: (1) Is there a specific somatosensory profile in our patient cohort? (2) Can we detect subgroups characterized by a specific combination of sensory and psychological features? and (3) Do psychological parameters influence sensory signs? Methods: In 87 patients with FMS quantitative sensory testing was performed on the hand and evaluated in combination with questionnaire results regarding pain, psychological comorbidities, sleep, and functionality. Results: Patients presented different somatosensory patterns, but no specific subgroups regarding sensory signs and psychological features were detected. Hypersensitivity for noxious mechanical and thermal stimuli and hyposensitivity for nonnoxious mechanical stimuli were the most prominent features. Thirty-one percent of patients showed signs of central sensitization as indicated by abnormally increased pinprick hyperalgesia or dynamic mechanical allodynia. Central sensitization was associated with higher pain intensities (P < 0.001). Only a small influence of psychiatric comorbidities on mechanical pain sensitivity (P = 0.044) and vibration detection (P = 0.028) was found, which was partly associated with high pain intensities. A small subgroup of patients (11.4%) demonstrated thermal hyposensitivity (loss of small-fiber function). Conclusion: Patients with FMS showed various somatosensory abnormalities. These were not significantly influenced by psychological comorbidities. Signs for central sensitization were detected in about one-third of patients and associated with higher pain intensities. This supports the notion of central sensitization being a major pathophysiological mechanism in FMS, whereas small-fiber loss may be less important.

16 April 2014 in BMC Public Health
Verified
Journal Article
Open access
PDF file
MFMarius S Fimland
Marius S Fimland
OVOttar Vasseljen
Ottar Vasseljen
SGSigmund Gismervik
Sigmund Gismervik
MRMarit By Rise
Marit By Rise
VHVidar Halsteinli
Vidar Halsteinli
RJRoar Johnsen
Roar Johnsen
Long-term sick leave has considerably negative impact on the individual and society. Hence, the need to identify effective occupational rehabilitation programs is pressing. In Norway, group based occupational rehabilitation programs merging patients with different diagnoses have existed for many years, but no rigorous evaluation has been performed. The described randomized controlled trial aims primarily to compare two structured multicomponent inpatient rehabilitation programs, differing in length and content, with a comparative cognitive intervention. Secondarily the two inpatient programs will be compared with each other, and with a usual care reference group.

22 May 2017 in Scandinavian Journal of Psychology
Verified
Journal Article
Closed access
PDF file
HJHenrik Børsting Jacobsen
Henrik Børsting Jacobsen
HKHåvard Kallestad
Håvard Kallestad
NLNils Inge Landrø
Nils Inge Landrø
PBPetter C. Borchgrevink
Petter C. Borchgrevink
TSTore C. Stiles
Tore C. Stiles

5 January 2020 in Scandinavian Journal of Work, Environment & Health
Verified
Journal Article
Open access
SGSigmund Ø Gismervik
Sigmund Ø Gismervik
LALene Aasdahl
Lene Aasdahl
OVOttar Vasseljen
Ottar Vasseljen
EFEgil A Fors
Egil A Fors
MRMarit B Rise
Marit B Rise
MFMarius S Fimland
Marius S Fimland
Objectives This study aimed to investigate whether inpatient multimodal occupational rehabilitation (I-MORE) reduces sickness absence (SA) more than outpatient acceptance and commitment therapy (O-ACT) among individuals with musculoskeletal and mental health disorders. Methods Individuals on sick leave (2-12 months) due to musculoskeletal or common mental health disorders were randomized to I-MORE (N=86) or O-ACT (N=80). I-MORE lasted 3.5 weeks in which participants stayed at the rehabilitation center. I-MORE included ACT, physical exercise, work-related problem solving and creating a return to work plan. O-ACT consisted mainly of 6 weekly 2.5 hour group-ACT sessions. We assessed the primary outcome cumulative SA within 6 and 12 months with national registry-data. Secondary outcomes were time to sustainable return to work and self-reported health outcomes assessed by questionnaires. Results SA did not differ between the interventions at 6 months, but after one year individuals in I-MORE had 32 fewer SA days compared to O-ACT (median 85 [interquartile range 33–149] versus 117 [interquartile range 59–189)], P=0.034). The hazard ratio for sustainable return to work was 1.9 (95% confidence interval 1.2–3.0) in favor of I-MORE. There were no clinically meaningful between-group differences in self-reported health outcomes. Conclusions Among individuals on long-term SA due to musculoskeletal and common mental health disorders, a 3.5-week I-MORE program reduced SA compared with 6 weekly sessions of O-ACT in the year after inclusion. Studies with longer follow-up and economic evaluations should be performed.

1 May 2015 in Journal of Psychosomatic Research
Verified
Journal Article
Open access
HKHåvard Kallestad
Håvard Kallestad
HJHenrik B. Jacobsen
Henrik B. Jacobsen
NLNils Inge Landrø
Nils Inge Landrø
PBPetter C. Borchgrevink
Petter C. Borchgrevink
TSTore C. Stiles
Tore C. Stiles
The definition of Chronic Fatigue Syndrome (CFS) overlaps with definitions of insomnia, but there is limited knowledge about the role of insomnia in the treatment of chronic fatigue. To test if improvement of insomnia during treatment of chronic fatigue was associated with improved outcomes on 1) fatigue and 2) cortisol recovery span during a standardized stress exposure. Patients (n = 122) with chronic fatigue received a 3.5-week inpatient return-to-work rehabilitation program based on Acceptance and Commitment Therapy, and had been on paid sick leave>8 weeks due their condition. A physician and a psychologist examined the patients, assessed medication use, and SCID-I diagnoses. Patients completed self-report questionnaires measuring fatigue, pain, depression, anxiety, and insomnia before and after treatment. A subgroup (n = 25) also completed the Trier Social Stress Test for Groups (TSST-G) before and after treatment. Seven cortisol samples were collected during each test and cortisol spans for the TSST-G were calculated. A hierarchical regression analysis in nine steps showed that insomnia improvement predicted improvement in fatigue, independently of age, gender, improvement in pain intensity, depression and anxiety. A second hierarchical regression analysis showed that improvement in insomnia significantly predicted the cortisol recovery span after the TSST-G independently of improvement in fatigue. Improvement in insomnia severity had a significant impact on both improvement in fatigue and the ability to recover from a stressful situation. Insomnia severity may be a maintaining factor in chronic fatigue and specifically targeting this in treatment could increase treatment response.